Immunoglobulin supplementation and longer dosing intervals reduce risk of infections in patients with RRMM treated with teclistamab.
Saved in:
| Title: | Immunoglobulin supplementation and longer dosing intervals reduce risk of infections in patients with RRMM treated with teclistamab. |
|---|---|
| Authors: | Smits F; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.; Department of Hematology, Haga Hospital, The Hague, the Netherlands., Groen K; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands., Korst CLBM; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands., Frerichs KA; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands., Kuipers I; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands., Kruyswijk S; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands., de Ruijter MEM; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands., Nasserinejad K; HOVON Data Center, Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands.; Department of Hematology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands., Zweegman S; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands., van de Donk NWCJ; Amsterdam UMC location Vrije Universiteit Amsterdam, Hematology, Amsterdam, The Netherlands. n.vandedonk@amsterdamumc.nl.; Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands. n.vandedonk@amsterdamumc.nl. |
| Source: | Blood cancer journal [Blood Cancer J] 2026 Feb 21; Vol. 16 (1). Date of Electronic Publication: 2026 Feb 21. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: United States NLM ID: 101568469 Publication Model: Electronic Cited Medium: Internet ISSN: 2044-5385 (Electronic) Linking ISSN: 20445385 NLM ISO Abbreviation: Blood Cancer J Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2044-5385 |
|---|---|
| DOI: | 10.1038/s41408-026-01451-9 |
